Andrew Blythe

Andrew Blythe is an attorney with patent litigation experience at Gibson Dunn & Crutcher LLP. His practice includes involvement in Patent Trial and Appeal Board (PTAB) proceedings, where he has represented petitioners.

Blythe has experience in intellectual property matters, including patent litigation. His work for petitioners in a PTAB case involving Merck Sharp & Dohme Corp. and its affiliates suggests a focus on pharmaceutical or life sciences technologies, often in the context of challenging patent validity. Tracked appearances indicate a plaintiff-side orientation.

He is admitted to practice before the U.S. Patent and Trademark Office, holding registration number 75,014. No specific undergraduate or law school education details are publicly available from the current search.